Design, rationale, and baseline demographics of SEARCH I: A prospective cluster-randomized study

International Journal of COPD

Volumn 7, Issue , 2012, Pages 437-445

  Albers, Frank ^a   Shaikh, Asif ^a   Iqbal, Ahmar ^b  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b PFIZER INC   (United States)

Author keywords

Case finding; COPD population screener; Copd 6 ; COPD PS ; Screening; Spirometry

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; ETHNICITY; HEALTH CARE PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SPIROMETER; SPIROMETRY; UNITED STATES; AGED; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; FEMALE; HEALTH SURVEY; INSTRUMENTATION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE;

AGED; CLUSTER ANALYSIS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESEARCH DESIGN; SPIROMETRY; UNITED STATES;

EID: 84871705603     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S31418     Document Type: Article

References (53)

1. Kleinschmidt P. Chronic Obstructive Pulmonary Disease and Emphy-sema in Emergency Medicine. Medscape Reference. October 10, 2011. Available from: http://emedicine.medscape.com/article/807143-overview#showall. Accessed November 1, 2011.
2. US National Heart Lung and Blood Institute. Morbidity and Mortality: the 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 2009.
3. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598-600.
4. van Schayck CP, Chavannes CN. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J. 2003; 21(Suppl 39):16S-22S.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160(11):1683-1689.
6. Calverley PM. COPD: early detection and intervention. Chest. 2000; 117(5 Suppl 2):365S-371S.
7. Barnes PJ, Adcock IM. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med. 2011;184(8): 866-867.
8. de Torres JP, Marin JM, Casanova C, et al. Lung cancer in patients with COPD: Incidence and predicting factors. Am J Respir Crit Care Med. Epub July 28, 2011.
9. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease; 2010. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed July 25, 2011.
10. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
11. American Thoracic Society, European Respiratory Society. Standards for the Diagnosis and Management of Patients with COPD. New York, NY: American Thoracic Society; 2004. Available from: http://www.thoracic.org/clinical/copd-guidelines/index.php. Accessed May 17, 2012.
12. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):529-534.
13. van den Boom G, van Schayck CP, van Möllen MP, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998;158(6):1730-1738.
14. Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001;119(3): 731-736.
15. Tirimanna PR, van Schayck CP, den Otter JJ, et al. Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract. 1996;46(406):277-281.
16. Duvall K, Frank GW. Identifying chronic obstructive pulmonary disease in primary care of urban underserved patients: tools, applications, and challenges. J Natl Med Assoc. 2010;102(7):570-578.
17. Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD. 2005;2(2):225-232.
18. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006; 73(3):285-295.
19. Dirven JA, Muris JW, van Schayck CP. COPD screening in general practice using a telephone questionnaire. COPD. 2010;7(5):352-359.
20. Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010;104(8):1160-1170.
21. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003; 1:13.
22. Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. Epub Jan 23, 2012.
23. Bailey WC, Sciurba FC, Hanania NA, et al. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009;18(3):198-207.
24. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
25. Miravitlles M, Llor C, Calvo E, Díaz S, Díaz-Cuervo H, Gonzalez-Rojas N. Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV(1)/FEV(6) for the diagnosis of COPD. Med Clin (Barc). Epub October 18, 2011. Spanish.
26. Beaumont JL, Victorson D, Su J, et al. Examining web equivalence and risk factor sensitivity of the COPD population screener. Value Health. 2011;14(4):506-512.
27. Enright P. Provide GPs with spirometry, not spirometers. Thorax. 2008;63(5):387-388.
28. Chan-Yeung M, Carlsten C. Reasonable alternatives to spirometry for diagnosing chronic obstructive pulmonary disease: is the peak flow meter the answer? Int J Tuberc Lung Dis. 2009;13(3):279-280.
29. Perez-Padilla R, Vollmer WM, Vázquez-García JC, Enright PL, Menezes AM, Buist AS; BOLD and PLATINO Study Groups. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009;13(3):387-393.
30. Gleeson S, Mitchell B, Pasquarella C, Reardon E, Falsone J, Berman L. Comparison of FEV6 and FVC for detection of airway obstruction in a community hospital pulmonary function laboratory. Respir Med. 2006;100(8):1397-1401.
31. Melbye H, Medbø A, Crockett A. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. Prim Care Respir J. 2006;15(5):294-298.
32. Bellia V, Sorino C, Catalano F, et al. Validation of FEV6 in the elderly: correlates of performance and repeatability. Thorax. 2008;63(1): 60-66.
33. Sorino C, Sherrill D, Guerra S, et al. Prognostic value of FEV1/FEV6 in elderly people. Clin Physiol Funct Imaging. 2011;31(2):101-107.
34. Rosa FW, Perez-Padilla R, Camelier A, Nascimento OA, Menezes AM, Jardim JR; Latin American Project for Investigation of Obstructive Lung Disease (PLATINO) Group. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res. 2007;40(12):1615-1621.
35. Jing JY, Huang TC, Cui W, Xu F, Shen HH. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest. 2009;135(4):991-998.
36. Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J. 2011; 20(2):190-198, 2 p following 198.
37. Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011;20(2): 184-189, 1 p following 189.
38. Represas Represas C, Botana Rial M, Leiro Fernández V, González Silva AI, del Campo Pérez V, Fernández-Villar A. Assessment of the portable copd-6 device for detecting obstructive airway diseases. Arch Bronconeumol. 2010;46(8):426-432. Spanish.
39. Gil-Guillén V, Orozco-Beltrán D, Carratala Munuera CV, et al; FUMEPOC Study Research Team. FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers. BMC Public Health. 2011;11:413.
40. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844-1850.
41. Roth CP, Kahn KL, Sherwood MJ, Rubenstein LV, Chew CF, Brook RH. Medical Record Abstraction Form and Guidelines for Assessing Quality of Care for Hospitalized Patients with Pneumonia. Santa Monica, CA: RAND Corporation; 1988. Publication N-2801-HCFA.
42. Murata PJ, McGlynn EA, Siu AL, et al. Quality measures for prenatal care. A comparison of care in six health care plans. Arch Fam Med. 1994;3(1):41-49.
43. Bauer P, Röhmel J, Maurer W, Hothorn L. Testing strategies in multi-dose experiments including active control. Stat Med. 1998;17(18): 2133-2146.
44. Littenberg B, MacLean CD. Intra-cluster correlation coefficients in adults with diabetes in primary care practices: the Vermont Diabetes Information System field survey. BMC Med Res Methodol. 2006; 6:20.
45. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403-409.
46. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004;59(2):120-125.
47. National Committee for Quality Assurance. The State of Health Care Quality 2008. Washington DC: National Committee for Quality Assurance; 2008. Available from: http://www.ncqa.org/portals/0/newsroom/sohc/SOHC_08.pdf. Accessed May 17, 2012.
48. Enright P, Quanjer P. Spirometry for COPD is both underutilized and overutilized. Chest. 2007;132(2):368-370.
49. Nelson SB, Thomashaw BM, Enright P, Mannino DM, Nemenoff EK. A tiered economical approach for COPD case-finding in the general population [abstract]. Am J Respir Crit Care Med. 2010;181:A5949.
50. Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550-556.
51. Brand PL, Rijcken B, Schouten JP, Koëter GH, Weiss ST, Postma DS. Perception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptoms. Am Rev Respir Dis. 1992;146(2):396-401.
52. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993;307(6901):422-424.
53. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20(4):799-805.